Form S-3/A - Registration statement under Securities Act of 1933: [Amend]
SEC Accession No. 0001654954-25-009073
Filing Date
2025-08-05
Accepted
2025-08-05 17:22:00
Documents
13

Document Format Files

Seq Description Document Type Size
1 FORM S-3 cvm_s3.htm S-3/A 311207
2 ATTACHMENT TO ARTICLES OF AMENDMENT cvm_ex3f.htm EX-3.F 1134
3 EX-5 cvm_ex5.htm EX-5 7486
4 CONSENT cvm_ex231.htm EX-23.1 2560
5 CONSENT cvm_ex232.htm EX-23.2 1827
6 FILING FEE TABLE cvm_ex107.htm EX-FILING FEES 34249
7 cvm_s3img21.jpg GRAPHIC 49320
8 cvm_s3img20.jpg GRAPHIC 34607
9 cvm_s3img19.jpg GRAPHIC 52161
10 cvm_s3img18.jpg GRAPHIC 39615
11 cvm_s3img17.jpg GRAPHIC 22571
12 cvm_s3img16.jpg GRAPHIC 26929
13 cvm_s3img15.jpg GRAPHIC 26405
  Complete submission text file 0001654954-25-009073.txt   706871
Mailing Address 8229 BOONE BLVD. SUITE 802 VIENNA VA 22182
Business Address 8229 BOONE BLVD . SUITE 802 VIENNA VA 22182 7035069460
CEL SCI CORP (Filer) CIK: 0000725363 (see all company filings)

EIN.: 840916344 | State of Incorp.: CO | Fiscal Year End: 0930
Type: S-3/A | Act: 33 | File No.: 333-288515 | Film No.: 251186238
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)